Softwr

AI · head to head

LatchBio vs Restate

LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Free plan
No
Restate logo

Restate

Developer Tools

Durable execution engine in Rust with a free tier and low-latency workflows

From
Free
Free plan
Yes

The short version

  • Restate starts at $300/mo; LatchBio prices on request.
  • Only LatchBio lists agent driven analysis; only Restate lists durable execution.
  • Prices and features on this page were last checked on 31 August 2026.

How do LatchBio and Restate differ?

LatchBio and Restate differ on starting price (On request against Free), pricing model and free tier (No against Yes). Only the attributes on which LatchBio and Restate actually diverge.

Attributes where LatchBio and Restate differ
AttributeLatchBioRestate
Starting priceOn requestFree
Pricing modelQuotePer month by durable action count
Free tierNoYes
PlatformsWebLinux, macOS, Web
CategoryAIDeveloper Tools

Which features does each one have?

They share no listed features; 6 appear only for LatchBio and 6 only for Restate. Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

Only in Restate

  • Durable execution
  • Virtual objects
  • Single binary runtime
  • Multi-language SDKs
  • Workflows and sagas
  • Restate Cloud

What is each one used for?

The jobs each tool is most often brought in to do.

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot Restate
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot Restate
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot Restate
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot Restate

Restate

  • Payment or order flows where a crash between two external API calls must not double-charge or lose the ordernot LatchBio
  • AI agent loops that call tools over minutes or hours and must survive a deployment mid-runnot LatchBio
  • Replacing hand-rolled retry, idempotency key and outbox code across a set of microservicesnot LatchBio
  • A small team that wants durable workflows without operating a Temporal cluster and its databasenot LatchBio

Where do LatchBio and Restate fall short?

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing

Restate

  • The runtime is under a Business Source Licence rather than an open source licence, so building a competing managed offering on it is prohibited and some procurement functions will reject it on licence grounds alone
  • Restate Cloud jumps from a free fifty thousand actions straight to 300 US dollars a month for twenty million, so a workload sitting at a few hundred thousand actions pays enterprise-shaped money for hobby-shaped volume
  • It is a young project against Temporal’s established base, so hiring engineers who already know it is unrealistic and the answer to most questions is in the docs rather than on Stack Overflow
  • The programming model requires structuring code around durable handlers and virtual objects, which is a genuine rewrite for existing services rather than a library you add
  • The single-binary simplicity that makes small deployments cheap also means fewer operational knobs at very large scale than a system designed as separable components

How much do LatchBio and Restate cost?

LatchBio is priced on request; Restate has a free plan, with paid plans from $300/mo. Plan by plan below, from each vendor's own pricing page.

LatchBio

On request
  • LatchBio PlatformOn request
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

Restate

Free
  • FreeFree
    • Fifty thousand durable actions per month
    • No credit card required
    • Community support
  • Starter$300/mo
    • Twenty million actions per month
    • Two hundred actions per second, bursting to one thousand
    • Twenty GB storage
  • Pro$1,000/mo
    • Fifty million actions per month
    • Five hundred actions per second, bursting to two thousand
    • Fifty GB storage
  • EnterpriseOn request
    • Negotiated volume
    • Twenty-four seven P0 support
    • 99.99 per cent SLA

Which should you pick?

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.

Choose Restate if

  • You need durable execution.
  • You want to start without paying.
  • You work on Linux, macOS, Web.
  • You also want virtual objects.

Questions people ask

Is LatchBio or Restate better?
Neither clearly leads. LatchBio starts at On request and Restate at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LatchBio or Restate?
Restate has a free tier; the other does not. Paid plans start at On request for LatchBio and Free for Restate.
Does LatchBio or Restate run on more platforms?
LatchBio runs on Web. Restate runs on Linux, macOS, Web.
Can I use Restate for free?
Yes. Restate has a free tier, so you can try it without paying. LatchBio starts at On request.
What is LatchBio best used for?
LatchBio is most often used for a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly, an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files, a wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facility, a research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegated. Of those, a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly and an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files are not what Restate is typically brought in for.
What can LatchBio do that Restate cannot?
LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals. Restate covers Durable execution, Virtual objects, Single binary runtime, Multi-language SDKs.

Answered from the vendors’ own pages

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

Restate: Is Restate open source?

The SDKs are MIT. The runtime is under a Business Source Licence, which permits self-hosting but not offering it as a competing service.

LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

Restate: How does it compare with Temporal?

Same problem, different shape: one Rust binary with embedded storage instead of a server plus database plus workers, and lower per-step latency.

LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

Restate: Is there a free tier?

Yes, fifty thousand durable actions a month on Restate Cloud with no card required.

LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Restate: Which languages are supported?

TypeScript, Java, Kotlin, Go, Python and Rust.

Share

Related pages

Other head to heads